Oncology Research

The Archer® FusionPlex Oncology Research panel is a targeted next-generation sequencing (NGS) test to simultaneously detect and identify fusions and other mutations associated with 74 genes found in ribonucleic acid (RNA) transcripts that are linked to various cancers. This panel is extensive and purpose-built to advance fusion discovery, including research efforts in the area of Ph-like acute lymphoblastic leukemia (ALL) fusions.
Key Features
Novel Fusion Detection

Anchored Multiplex PCR (AMP™) chemistry allows for identification of novel fusion partners.

Expert Design

Designed for all breakpoints from a vast, internally curated knowledge base.


The most comprehensive FusionPlex panel available, including critical pediatric markers such as Ph-ALL fusions.

Specifications and Performance


Gene Targets

> 10ng

Input Nucleic Acid Required*

> 96%

Unique Molecular On-Target %

2.5 hours

Hands-on Time

9 hours

Total Time

Illumina and
Ion Torrent


Fresh Frozen or FFPE

Sample Types

*Input recommendations for FFPE samples vary depending on Archer PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening

Gene Targets


Fusion, splicing or exon-skipping

NeeD to Modify Your Panel?

Add any of our wet lab-validated designs to this panel with Archer Assay Designer to build an assay that fits your exact requirements.

  • Find Your Fit

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.